col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


105 Results       Page 1

 [1] 
Springer-Verlag: Molecular Biology Reports
  original article Date Title Authors   All Authors
1 [GO] 2025―Jan―31 Upregulation of the MAP2K4 gene triggers endothelial-mesenchymal transition in COVID-19 Esra Yilmaz, Dilek Yilmaz, Can Gokay Yildiz, Ercan Cacan
2 [GO] 2025―Jan―08 The first assessment of Angiotensin-Converting Enzyme 1 (ACE1) D/I polymorphism and demographic factors in association with COVID-19 outcomes in the Moroccan Population Ihssane El Bouchikhi, Ihsane El Otmani, Mohamed Ahakoud, Oussama Kettani, Badreddine El Makhzen, Ghita Yahyaoui, et al. (+6)
3 [GO] 2024―Oct―28 Characterization of the viral genome of Omicron variants of SARS-CoV-2 circulating in Tripura, a remote frontier state in Northeastern India Ankan Chakrabarti, Saikat Majumder, Apurba Sarkar, Tapan Majumdar
4 [GO] 2024―Oct―21 Potential hypothesis for the increased risk of Parkinson´s disease following COVID-19 Raffaella Mormile, Cristina Mormile, Carmine Picone
5 [GO] 2024―Aug―27 COVID-19 increases mortality in hemodialysis patients: exploring links with inflammation and telomere attrition Tamara Milosevic, Radomir Naumovic, Miron Sopic, Jelena Vekic, Azra Guzonjic, Snezana Pesic, et al. (+2)
6 [GO] 2024―Aug―08 Adenosine A2AR in viral immune evasion and therapy: unveiling new avenues for treating COVID-19 and AIDS Muhammad Atif, Abdullah Alsrhani, Farrah Naz, Sajjad Ullah, Abualgasim Elgaili Abdalla, Muhammad Ikram Ullah, et al. (+4)
7 [GO] 2024―Aug―07 Development of highly adaptable RT-PCR methods for identifying Delta and BA.1 variants in inactivated COVID-19 vaccines Zhanhui Wang, Yao He, Zhenyu He, Yancen Guo, Yuxiu Zhao, Yuntao Zhang
8 [GO] 2024―Jul―25 Cycle threshold (Ct)values of SARS-CoV2 vary with the type of symptoms and comorbidities of the patients Naila Shoaib, Rimsha Munir
9 [GO] 2024―Jul―23 The study of single nucleotide polymorphism in a promoter region of ACE-2 receptor gene in the samples of Iraqi population with COVID-19 Ali H. Mahmood, Salwa J. Al-Awadi, Noora A. Hadi, Marwa M. Al-Attar
10 [GO] 2024―Jul―15 The relationship between Nuclear Factor-Kappa B and Inhibitor-Kappa B parameters with clinical course in COVID-19 patients Melek Karasu, Muhdi Cevik, Serap Biberoglu, Emine Selva Kaplanoglu, Nilgun Cetinkaya, Dildar Konukoglu, Mine Kucur
11 [GO] 2024―May―25 Alternations in miR-155 and miR-200 serum levels can serve as biomarkers for COVID-19 in the post-mass vaccination era Aliaa Aboulela, Mona Taha, Abeer Ghazal, Ayman Baess, Amel Elsheredy
12 [GO] 2024―May―22 Nasal carriage of virulent and multidrug resistant Staphylococcus aureus: a possible comorbidity of COVID-19 Muinah Adenike Fowora, Adenike Aiyedogbon, Ibilola Omolopo, Ahmed Oluwasegun Tajudeen, Faustina Onyeaghasiri, Idowu Edu-Muyideen, et al. (+7)
13 [GO] 2024―May―08 Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia Valeriy Pokhylko, Yuliia Cherniavska, Liliia Fishchuk, Zoia Rossokha, Olena Popova, Viktoriia Vershyhora, et al. (+4)
14 [GO] 2024―Apr―25 Correction: Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE Kevin Maafu Juma, Kenta Morimoto, Vishnu Sharma, Kirti Sharma, Radhika Biyani, Manish Biyani, et al. (+2)
15 [GO] 2024―Feb―24 Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection Carolyn Krause, Eva Bergmann, Susanne Viktoria Schmidt
16 [GO] 2024―Feb―22 COVID-19 and the brain: understanding the pathogenesis and consequences of neurological damage Sumaiya Tasnim Maliha, Rabeya Fatemi, Yusha Araf
17 [GO] 2024―Feb―20 Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection Yousef Rasmi, Ighli di Bari, Shah Faisal, Munima Haque, Pornanong Aramwit, Aline da Silva, Elmira Roshani Asl
18 [GO] 2024―Feb―10 Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal? Ramiar Kamal Kheder, Omeed Darweesh, Bashdar Mahmud Hussen, Snur Rasool Abdullah, Abbas Basiri, Mohammad Taheri
19 [GO] 2024―Feb―08 Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE Kevin Maafu Juma, Kenta Morimoto, Vishnu Sharma, Kirti Sharma, Radhika Biyani, Manish Biyani, et al. (+2)
20 [GO] 2024―Jan―25 Evidence of SARS-CoV-2 infection in companion animals from owners who tested positive for COVID-19 in the Valley of Mexico Edith A. Fernández-Figueroa, Deborah V. Espinosa-Martínez, Haydee Miranda-Ortiz, Erika Ruiz-García, Juan M. Figueroa-Esquivel, Miriam L. Becerril-Moctezuma, et al. (+2)
21 [GO] 2024―Jan―22 ACE I/D polymorphism is a risk factor for the clinical severity of COVID-19 in Brazilian male patients Sandro Soares Almeida, Marcos Fernandes Gregnani, Isabela Moreira Gontijo da Costa, Matheus Matias da Silva, Carolina Bonet Bub, Valmir Oliveira Silvino, et al. (+2)
22 [GO] 2024―Jan―06 MBOAT7 expression is associated with disease progression in COVID-19 patients Eman Radwan, Ahmed Abdelaziz, Manal A. M. Mandour, Abdel-Raheim M. A. Meki, Maha M. El-kholy, Marwan N. Mohamed
23 [GO] 2023―Nov―07 Prognostic potential of circulating cell free mitochondrial DNA levels in COVID-19 patients Ata Mahmoodpoor, Mojtaba Mohammadzadeh, Rogayyeh Asghari, Majid Tagizadeh, Afshin Iranpour, Mansour Rezayi, et al. (+4)
24 [GO] 2023―Nov―02 Correction to: association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients Samaneh Ramezani, Fatemeh Ezzatifar, Tahereh Hojjatipour, Maryam Hemmatzadeh, Arezoo Gowhari Shabgah, Jamshid Gholizadeh Navashenaq, et al. (+10)
25 [GO] 2023―Oct―29 Endangered shark species traded as “cação” in São Paulo during the COVID-19 lockdown: DNA-barcoding a snapshot of products Veronica Zuccolo, Fernanda Moreira Rego, Emily Hughes, Andrew M. Griffiths
26 [GO] 2023―Oct―24 Assessing the gene expression of the adenosine 5′-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients Shirin Assar, Mohammad Dastbaz, Komail Amini, Seyed Askar Roghani, Ramin Lotfi, Mahdi Taghadosi, et al. (+5)
27 [GO] 2023―Oct―10 Molecular diagnostic approaches for SARS-CoV-2 detection and pathophysiological consequences Camila Salazar-Ardiles, Leyla Asserella-Rebollo, Carlos Cornejo, Dayana Arias, Manuel Vasquez-Muñoz, Camilo Toledo, David C. Andrade
28 [GO] 2023―Oct―10 Altered expression levels of TAS1R2 and TAS1R3 genes among SARS-CoV-2 variants of concerns Qendresa Hoti, Gokce Akan, Gulten Tuncel, Emine Unal Evren, Hakan Evren, Kaya Suer, et al. (+2)
29 [GO] 2023―Sep―23 Stem cell-derived organoid models for SARS-CoV-2 and its molecular interaction with host cells Ladan Dawoody Nejad, Lisa Marie Julian
30 [GO] 2023―Aug―29 Assessment of thermal and temporal stability of SARS-CoV-2 samples using real-time qRT-PCR Rohit Kumar Swain, S. S. Mohanty, Mahendra Thakor, A. K. Sharma
31 [GO] 2023―Jul―08 Genetic variability of rice stripe virus after its pandemic in Jiangsu Chengye Lu, Qian Miu, Daoran Jin, Aiguo Li, Zhaobang Cheng, Yijun Zhou, et al. (+2)
32 [GO] 2023―Jul―07 Histological and molecular response of oral cavity tissues to Covid-19 Nehad M. Abd-elmonsif, Sherif Gamal
33 [GO] 2023―Jun―27 Association between angiotensin-converting enzyme-2 gene polymorphism (rs2106809) with severity and outcome of COVID-19 infection Hamideh Mohammadi-Berenjestanaki, Elaheh Mohammadali, Mina Khasayesi, Alireza Rafiei, Zahra Kashi, Narges Mirzaei-Ilali, Zahra Hosseini-khah
34 [GO] 2023―Jun―08 Synergistic effect of elevated glucose levels with SARS-CoV-2 spike protein induced NOX-dependent ROS production in endothelial cells Jiahao Zhang, Li He, Rong Huang, Juan Felipe Alvarez, David H. Yang, Qihao Sun, et al. (+4)
35 [GO] 2023―May―25 Association between mannose binding lectin gene polymorphisms and clinical severity of COVID-19 in children Dilek Yilmaz, Mustafa Soyoz, Aslıhan Sahin, Burcu Cerci-Alkac, Hatice Ilayhan Karahan-Coven, Yıldız Ekemen-Keles, et al. (+4)
36 [GO] 2023―May―24 Angiotensin converting enzyme 2 gene expression and markers of oxidative stress are correlated with disease severity in patients with COVID-19 Afraa S. H. Alobaidy, Mona Elhelaly, Maggie E. Amer, Rasha S. Shemies, Azza I. Othman, Mohamed A. El-Missiry
37 [GO] 2023―Apr―29 Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome Peshnyar M.A. Rashid, Gaza F. Salih
38 [GO] 2023―Mar―15 Genetic analysis of ACE2 peptidase domain in SARS-CoV-2-positive and SARS-CoV-2-negative individuals from Pakistan Noor Muhammad, Humaira Naeemi, Ayesha Azeem, Rida Sadaqat, Umara Shehzad, Kashif Siddique, et al. (+3)
39 [GO] 2023―Jan―28 Evaluation of both expression and serum protein levels of caspase-8 and mitogen-activated protein kinase 1 genes in patients with different severities of COVID-19 infection Murat Acat, Pınar Yıldız Gülhan, Recep Eröz, Ayşegül Ertınmaz Özkan, Oğuzhan Koca, Caner Çınar
40 [GO] 2023―Jan―05 Association between iron metabolism and SARS-COV-2 infection, determined by ferritin, hephaestin and hypoxia-induced factor-1 alpha levels in COVID-19 patients Elif Sibel Aslan, Hüseyin Aydın, Yusuf Kenan Tekin, Sami Keleş, Kenneth N. White, Nezih Hekim
41 [GO] 2022―Dec―27 Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2 Jiewen Fu, Binghui Song, Jiaman Du, Shuguang Liu, Jiayue He, Ting Xiao, et al. (+6)
42 [GO] 2022―Dec―23 Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective Subhomoi Borkotoky, Debajit Dey, Zaved Hazarika
43 [GO] 2022―Dec―20 Therapeutic role of mTOR inhibitors in control of SARS-CoV-2 viral replication Tuba Khalid, Adria Hasan, Jamal e Fatima, Soban Ahmad Faridi, Ahamad Faiz Khan, Snober S. Mir
44 [GO] 2022―Dec―19 Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2 Vishal Khandelwal, Tarubala Sharma, Saurabh Gupta, Shoorvir Singh, Manish Kumar Sharma, Deepak Parashar, Vivek K. Kashyap
45 [GO] 2022―Dec―07 The alternative renin-angiotensin-system (RAS) signalling pathway in prostate cancer and its link to the current COVID-19 pandemic Fabian Sehn, Hartwig Büttner, Beate Godau, Marten Müller, Semih Sarcan, Anne Offermann, et al. (+4)
46 [GO] 2022―Nov―01 Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients Samaneh Ramezani, Fatemeh Ezzatifar, Tahereh Hojjatipour, Maryam Hemmatzadeh, Arezoo Gowhari Shabgah, Jamshid Gholizadeh Navashenaq, et al. (+10)
47 [GO] 2022―Oct―29 Retinoic acid-inducible gene 1 (RIG-1) and IFN-β promoter stimulator-1 (IPS-1) significantly down-regulated in the severe coronavirus disease 2019 (COVID-19) Peyman Nahavandi-Parizi, Ashraf Kariminik, Maryam Montazeri
48 [GO] 2022―Sep―22 Lectins from plant and algae act as anti-viral against HIV, influenza and coronaviruses Sanjay Naik, Sanjit Kumar
49 [GO] 2022―Sep―12 Non-coding RNA in idiopathic interstitial pneumonia and Covid-19 pulmonary fibrosis Mohammad Shadab Ali, Jay Singh, Md Tanjim Alam, Anita Chopra, Sudheer Arava, Ashu Seith Bhalla, et al. (+4)
50 [GO] 2022―Sep―12 Nitazoxanide and COVID-19: A review Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Engy Elekhnawy, Gaber El-Saber Batiha
51 [GO] 2022―Jul―09 Potential autonomic nervous system dysfunction in COVID-19 patients detected by heart rate variability is a sign of SARS-CoV-2 neurotropic features Maryame Mohammadian, Ravieh Golchoobian
52 [GO] 2022―Jul―07 Preliminary investigation of gene expression levels of PAPP-A, STC-2, and HIF-1α in SARS-Cov-2 infected patients Sevgi Karabulut Uzunçakmak, Muhammet Emin Naldan, Ebubekir Dirican, Ferhan Kerget, Zekai Halıcı
53 [GO] 2022―Jul―06 An outlook on potential protein targets of COVID-19 as a druggable site Rubia Noori, Meryam Sardar
54 [GO] 2022―Jun―26 SARS-CoV-2 cell entry beyond the ACE2 receptor Shamila D. Alipoor, Mehdi Mirsaeidi
55 [GO] 2022―Jun―13 Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq Peshnyar M. A. Rashid, Gaza F. Salih
56 [GO] 2022―May―24 Antimicrobial peptides: features, applications and the potential use against covid-19 Dalia Mamdouh Mabrouk
57 [GO] 2022―May―21 A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseases Devasahayam Arokiar Balaya Rex, Neelanchal Vaid, K. Deepak, Shobha Dagamajalu, T. S. Keshava Prasad
58 [GO] 2022―May―21 Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage Sneh Lata Gupta, Rishi K. Jaiswal
59 [GO] 2022―May―08 Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice Yanaysi Ceballo, Alina López, Carlos E. González, Osmany Ramos, Iván Andújar, Ricardo U. Martínez, Abel Hernández
60 [GO] 2022―Apr―20 Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics Huriye Erbak Yılmaz, Evin Iscan, Ozden Oz, Tuğçe Batur, Aybike Erdoğan, Seval Kılıç, et al. (+3)
61 [GO] 2022―Apr―07 Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2 Ismail Celil Haskologlu, Emine Erdag, Serkan Sayiner, Nurettin Abacioglu, Ahmet Ozer Sehirli
62 [GO] 2022―Mar―24 Factors associated with cycle threshold values (Ct-values) of SARS-CoV2-rRT-PCR Naila Shoaib, Naila Noureen, Arwa Faisal, Muhammad Zaheer, Muhammad Imran, Ali Ahsan, et al. (+2)
63 [GO] 2022―Mar―17 Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results Aline de Souza Nicoletti, Marília Berlofa Visacri, Carla Regina da Silva Correa da Ronda, Pedro Eduardo do Nascimento Silva Vasconcelos, Julia Coelho França Quintanilha, Rafael Nogueira de Souza, et al. (+13)
64 [GO] 2022―Mar―06 Association of severity and mortality of Covid-19 cases among acute kidney injury and sexual dimorphism Mukul Kumar Singh, Mayank Jain, Hari Shyam, Dinesh Kumar Sahu, Archana Mishra, Pratap Shankar, et al. (+2)
65 [GO] 2022―Mar―02 Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms Ameneh Jafari, Fahima Danesh Pouya, Zahra Niknam, Meghdad Abdollahpour-Alitappeh, Mostafa Rezaei-Tavirani, Yousef Rasmi
66 [GO] 2022―Feb―15 Ameliorating effects of probiotics on alterations in iron homeostasis and inflammation in COVID-19 Eman M. El-Sayed, Khadiga S. Ibrahim
67 [GO] 2022―Feb―02 Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients P. Monika, M. N. Chandraprabha
68 [GO] 2022―Jan―31 Modified uvsY by N-terminal hexahistidine tag addition enhances efficiency of recombinase polymerase amplification to detect SARS-CoV-2 DNA Kevin Maafu Juma, Teisuke Takita, Masaya Yamagata, Mika Ishitani, Kaichi Hayashi, Kenji Kojima, et al. (+7)
69 [GO] 2022―Jan―31 Evaluating the effects of sodium glucose co-transporter -2 inhibitors from a renin-angiotensin-aldosterone system perspective in patients infected with COVID-19: contextualizing findings from the dapagliflozin in respiratory failure in patients with COVID-19 study Diala Alhaj Moustafa, Zainab Imran, Roua Ismail, Menatallah Rayan, Alain-Pierre Gadeau, Hussein Eldassouki, et al. (+2)
70 [GO] 2022―Jan―25 Blocking TNF signaling may save lives in COVID-19 infection Vitaly Ablamunits, Christopher Lepsy
71 [GO] 2022―Jan―24 The COVID-19-diabetes mellitus molecular tetrahedron Mehdi Mahmudpour, Katayoun Vahdat, Mohsen Keshavarz, Iraj Nabipour
72 [GO] 2022―Jan―22 Resolving the equation between mucormycosis and COVID-19 disease Ritu Pasrija, Mohammad Naime
73 [GO] 2022―Jan―14 Mini review ATF4 and GRP78 as novel molecular targets in ER-Stress modulation for critical COVID-19 patients Mahtab Shahriari-Felordi, Hani Keshavarz Alikhani, Seyed-Mohammad Reza Hashemian, Moustapha Hassan, Massoud Vosough
74 [GO] 2022―Jan―06 Neutralizing antibody: a savior in the Covid-19 disease Sneh Lata Gupta, Rishi Kumar Jaiswal
75 [GO] 2022―Jan―02 Correction to: A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR Fadi Abdel Sater, Mahmoud Younes, Hassan Nassar, Paul Nguewa, Kassem Hamze
76 [GO] 2021―Nov―27 Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection Antonio Vitiello, Francesco Ferrara
77 [GO] 2021―Nov―09 Bioprospecting of microalgae metabolites against cytokine storm syndrome during COVID-19 Che Lah Wan Afifudeen, Kit Yinn Teh, Thye San Cha
78 [GO] 2021―Oct―28 COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression Tahani Tabassum, Yusha Araf, Abu Tayab Moin, Tanjim Ishraq Rahaman, Mohammad Jakir Hosen
79 [GO] 2021―Oct―19 Niclosamide for Covid-19: bridging the gap Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Khalid J. Alzahrani, Athanasios Alexiou, Gaber El-Saber Batiha
80 [GO] 2021―Oct―16 The effect of COVID-19 derived cytokine storm on cancer cells progression: double-edged sword Mohammad Heydarian, Mohammadjavad Mohammadtaghizadeh, Mahboobeh Shojaei, Marziyeh Babazadeh, Sadegh Abbasian, Mehran Amrovani
81 [GO] 2021―Oct―15 Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19 Azadeh Manayi, Seyed Mohammad Nabavi, Maryam Khayatkashani, Solomon Habtemariam, Hamid Reza Khayat Kashani
82 [GO] 2021―Oct―14 The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, Tayebeh latifi
83 [GO] 2021―Oct―13 Corticosteroids for COVID-19: worth it or not? Fariya Akter, Yusha Araf, Mohammad Jakir Hosen
84 [GO] 2021―Oct―07 A rapid and low-cost protocol for the detection of B.1.1.7 lineage of SARS-CoV-2 by using SYBR Green-based RT-qPCR Fadil Abdel Sater, Mahmoud Younes, Hassan Nassar, Paul Nguewa, Kassem Hamze
85 [GO] 2021―Sep―12 Regenerated silica-based RNA purification columns to address the short supply of RNA purification kits for COVID-19 diagnosis Jitendra K. Biswal, Rajeev Ranjan, Shyam Singh Dahiya, Smrutirekha Mallick, Jajati K. Mohapatra
86 [GO] 2021―Aug―16 Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches Hany E. Marei, Asmaa Althani, Nahla Afifi, Giacomo Pozzoli, Thomas Caceci, Franco Angelini, Carlo Cenciarelli
87 [GO] 2021―Aug―15 How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels? Maryam Noori, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Kristin Carson-Chahhoud, Mohammadreza Ardalan, Ali-Asghar Kolahi, Saeid Safiri
88 [GO] 2021―Aug―12 Genomic evolution of the human and animal coronavirus diseases Carla Miranda, Vanessa Silva, Gilberto Igrejas, Patrícia Poeta
89 [GO] 2021―Jul―22 Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection K. A. Dvornikova, E. Yu. Bystrova, L. P. Churilov, A. Lerner
90 [GO] 2021―May―22 Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges Ismail Sami Mahmoud, Yazun Bashir Jarrar
91 [GO] 2021―May―03 miR-200c-3p upregulation and ACE2 downregulation via bacterial LPS and LTA as nteresting aspects for COVID-19 treatment and immunity Saber Soltani, Milad Zandi
92 [GO] 2021―Apr―23 Silent hypoxia in COVID-19: pathomechanism and possible management strategy Ahsab Rahman, Tahani Tabassum, Yusha Araf, Abdullah Al Nahid, Md. Asad Ullah, Mohammad Jakir Hosen
93 [GO] 2021―Apr―10 COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies Habib Haybar, Mahmood Maniati, Najmaldin Saki, Zeinab Deris Zayeri
94 [GO] 2021―Feb―23 Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review Maria Elisabetta Onori, Claudio Ricciardi Tenore, Andrea Urbani, Angelo Minucci
95 [GO] 2021―Jan―23 SARS-COV-2 infection and lung tumor microenvironment Naila Malkani, Muhammad Usman Rashid
96 [GO] 2021―Jan―22 The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19 Xingjuan Shi, Mengying Chen, Yu Zhang
97 [GO] 2020―Dec―12 BRCA testing delay during the COVID-19 pandemic: How to act? Angelo Minucci, Giovanni Scambia, Maria De Bonis, Elisa De Paolis, Concetta Santonocito, Anna Fagotti, et al. (+3)
98 [GO] 2020―Nov―13 Potential approaches to combat COVID-19: a mini-review Zainab Sarwar, Tahir Ahmad, Salik Kakar
99 [GO] 2020―Oct―26 A comparative phylogenomic analysis of SARS-CoV-2 strains reported from non-human mammalian species and environmental samples Aziz Ul-Rahman, Muhammad Abu Bakr Shabbir, Muhammad Waqar Aziz, Saima Yaqub, Asif Mehmood, Muhammad Asif Raza, Muhammad Zubair Shabbir
100 [GO] 2020―Oct―06 Recent advances in the nucleic acid-based diagnostic tool for coronavirus Pranav Kumar Prabhakar, Jyoti Lakhanpal
101 [GO] 2020―Sep―12 Intussusceptive angiogenesis in Covid-19: hypothesis on the significance and focus on the possible role of FGF2 Simone Meini, Tommaso Giani, Carlo Tascini
102 [GO] 2020―Sep―12 Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147) Ahmet Ozer Sehirli, Serkan Sayiner, Nedime Serakinci
103 [GO] 2020―Jun―29 A contemporary review on pathogenesis and immunity of COVID-19 infection Rasoul Mirzaei, Sajad Karampoor, Mohammad Sholeh, Pouya Moradi, Reza Ranjbar, Faezeh Ghasemi
104 [GO] 2020―May―14 Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19 Jiewen Fu, Baixu Zhou, Lianmei Zhang, Kyathegowdanadoddi Srinivasa Balaji, Chunli Wei, Xiaoyan Liu, et al. (+3)
105 [GO] 2020―May―09 BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic Angelo Minucci, Giovanni Scambia, Concetta Santonocito, Paola Concolino, Andrea Urbani
 [1] 

105 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.024 sec